TrialInvestigational new drugs2012

A multicenter phase II study of the stop-and-go modified FOLFOX6 with bevacizumab for first-line treatment of patients with metastatic colorectal cancer.

Natsuko T Okita et al.PubMed ↗Publisher ↗

No numbers read from the abstract.